参考文献/References:
[1] Moog F,Bangerter M,Diederichs CG,et al.Extran-odal malignant lymphoma:detection with 18F-FDG PET versus CT[J].Radiology,1998,206(2):475-481.
[2] Thill R,Neuerburg J,Fabry U,et al.Comparison of findings with 18-F-FDG PET and CT in pretherapeutic staging of malignant lymphoma[J].Nukearmedizin,1997,36(7):234-239.
[3] Hoh CK,Glaspy J,Rosen P,et al.Whole-body 18F-FDG PET imaging for staging of Hodgkin’s disease and lymphoma[J].J Nucl Med,1997,38(3):343-348.
[4] Moog F,Kotzerke J,Reske SN.18F-FDG PET call replace bone scintigraphy in primary stagiag of malig-nant lymphoma[J].J Nucl Med,1999,40(9):1407-1413.
[5] Carr R,Barrington SF,Madan B.et al.Detection of lymphoma in bone marrow by whole-body positron e-mission tomoraphy[J].Blood,1998,91(9):3340-3346.
[6] Moog F,Bangerter M,Kotzerke J,et al.18-F-fluo-rodeoxyglucose-positron emission tomograpby as a new approach to detect lymphomatous bone marrow[J].J Clin Oncol,1998,16(2):603-609.
[7] Lapela M,Leskiinen S,Minn HR,et al.Hlcreased glucose metabolism in mlffeated non-Hodgkin’s lym-phoma:a study with positon emission tomography and fluorine-18-auorodeoxyglucose[J].Blood,1995,86(9):3522-3527.
[8] Jerusalem G,Begnin Y,Fassotte M F,et al.Persis-tent tumor 18F-FDG uptake after a few cycles of poly-chemotherapy is predictive of treatment failure in non-Hodgkin’s lymphoma[J].Haematologica,2000,85(6):613-618.
[9] Romer W,Hallauske AR,Ziegler S,et al.Positron e-mission tomography in non-Hodgkin’s lymphoma:as-sessment of chemodlerapy with fluorodeoxyglucose[J].Blood,1998,91(12):4464-4471.
[10] Calleuos GP.Residual mass in lymphoma may not be residual disease[J].J Clin Oncol,1988,6(6):931.
[11] De Wit M,Bumann D,Beyer W,et al.Whole-body positron emission tomography (PET) for diagnosis of residual mass in patient with lymphoma[J].Ann On-col,1997,8(suppl 1):57-60.
[12] Cremerius U,Fabry U,Neuerbmg J,et al.Positron emission tomography widl 18F-FDG to detect residual disease after dlerapy for malignant lymphoma[J].Nu-cl Med Commun,1998,19(11):1055-1063.
[13] Maisey NR,Hill M E,Webb A,et al.Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the predic-tion of relapse in lymphoma residual masses?[J].Eur J Cancer,2000,36(2):200-206.
[14] Shin M S,HO KJ.Diffuse thymic hyperplasia follow-ing chemotherapy for nodular sclerosing Hodgkin’s disease:An immunologic rebound phenomenon?[J].Cancer,1983,51(1):30-33.
[15] Wenblatt M E,Zanzi I,Belakhlef A,et al.False-posi-tive 18F-FDG PET imaging of the thymus of a child with Hodgkin’s disease[J].JNucl Med,1997,38(6):888-890.
[16] Jerusalem G,Beguin Y,Fassotte M F,et al.Whole-body positron emission tomography using 18F-fluo-rodeoxyglucse for posttreatrment evaluation in Hodgkin’s disease and non-Hodgkin’s lymphoma has higher diagnostic and prognostic value than classical computer tomography scan imaging[J].Blood,1999,94(2):429-433.
相似文献/References:
[1]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[2]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[3]胡娜,吴永港,肖立志,等.18F-FDG PET/CT代谢活性参数及其在淋巴瘤中的应用[J].国际放射医学核医学杂志,2015,39(4):342.[doi:10.3760/cma.j.issn.1673-4114.2015.04.015]
Hu Na,Wu Yonggang,Xiao Lizhi,et al.Metabolic parameters of 18F-FDG PET/CT and their application in lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):342.[doi:10.3760/cma.j.issn.1673-4114.2015.04.015]
[4]戴娜,吴翼伟.影像学技术在霍奇金淋巴瘤诊疗中的价值[J].国际放射医学核医学杂志,2014,38(2):117.[doi:10.3760/cma.j.issn.1673-4114.2014.02.011]
Dai Na,Wu Yiwei.The value of medical imaging methods in diagnosis and treatment of Hodgkin lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):117.[doi:10.3760/cma.j.issn.1673-4114.2014.02.011]
[5]杨希,党春江.泌尿系统原发性结外淋巴瘤的临床及影像学表现[J].国际放射医学核医学杂志,2013,37(4):230.[doi:10.3760/cma.j.issn.1673-4114.2013.04.010]
YANG Xi,DANG Chun-jiang.The clinical and imaging appearances of primary extranodal lymphoma of the urinary system[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):230.[doi:10.3760/cma.j.issn.1673-4114.2013.04.010]
[6]李艳梅,杨建伟,李鹏,等.单眼虹膜原发非霍奇金淋巴瘤18F-FDGPET/CT显像及疗效评价一例[J].国际放射医学核医学杂志,2013,37(5):326.[doi:10.3760/cma.j.issn.1673-4114.2013.05.017]
[7]萨日,赵红光,关锋,等.18F-FDG PET/CT在弥漫性大B细胞淋巴瘤疗效评价中的临床价值[J].国际放射医学核医学杂志,2013,37(1):9.[doi:10.3760/cma.j.issn.1673-4114.2013.01.003]
SA Ri,ZHAO Hong-guang,GUAN Feng,et al.Clinical value of 18F-FDG PET/CT in evaluation of curative effect on diffuse large B cell lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):9.[doi:10.3760/cma.j.issn.1673-4114.2013.01.003]
[8]王月英,吴红英,李德冠,等.小鼠不同肿瘤模型对放化疗敏感性的研究[J].国际放射医学核医学杂志,2012,36(5):289.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.006]
WANG Yue-ying,WU Hong-ying,LI De-guan,et al.The radiation sensitivities of different mice tumor model to radiotherapy and chemotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(1):289.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.006]
[9]李倩,刘建军.18F-FDG PET-CT评价淋巴瘤疗效及预后的价值[J].国际放射医学核医学杂志,2011,35(4):220.[doi:10.3760/cma.j.issn.1673-4114.2011.04.006]
LI Qian,LIU Jian-jun.The value of 18F-FDG PET-CT in lymphoma therapy evaluation and prognosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):220.[doi:10.3760/cma.j.issn.1673-4114.2011.04.006]
[10]崔玥婵,朱晓琳,张雪君.超声引导下穿刺活检术对颈部淋巴结诊断的现状及进展[J].国际放射医学核医学杂志,2011,35(6):369.[doi:10.3760,cma.j.issn.1673-4114.2011.06.013]
CUI Yue-chaan,ZHU Xiao-lin,ZHANG Xue-jun.Status and advances of cervical lymph nodes diagnosis by ultrasound-guided core-needle biopsy[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):369.[doi:10.3760,cma.j.issn.1673-4114.2011.06.013]
[11]华逢春,管一晖,赵军.18F-氟代脱氧葡萄糖PET及PET-CT在淋巴瘤中的临床应用[J].国际放射医学核医学杂志,2005,29(5):216.
HUA Feng-chun,GUAN Yi-hui,ZHAO Jun.18F-FDG PET and PET-CT imaging in lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):216.
[12]赵晋华.18F-FDG PET在淋巴瘤分期和治疗反应评价中的价值[J].国际放射医学核医学杂志,2004,28(5):210.
ZHAO Jin-hua.18F-FDG PET in the staging and evaluating of the response to therapy for lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(1):210.